Immunobiology of Influenza Virus Infection: Approaches for an Emerging Zoonotic D
Immunobiology of Influenza Virus Infection: Approaches for an Emerging Zoonotic D
批准号:
7334084
负责人:
RALPH A TRIPP
金额:
$2.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-06-15 至 2008-05-31
关键词:
AcademiaAnimalsApplied ResearchBasic ScienceCellsDevelopmentEmerging Communicable DiseasesFosteringGenerationsGoalsGovernmentHumanHuman VirusImmuneImmune systemImmunityImmunobiologyImmunologistIndustryInfectionInfluenza A Virus, H5N1 SubtypeMaintenanceMemoryPharmaceutical PreparationsTherapeuticTranslationsVaccine TherapyVaccinesViralViral VaccinesVirusVirus Diseasesinfluenzavirusresponse
中文摘要
大多数新出现的传染病是人畜共患病,即
英文摘要
The majority of emerging infectious diseases are of zoonotic origin, i.e.
transmissible between humans and animals causing infection in both species. Many of the
most dangerous and easily transmitted of these agents are viruses. The majority of the
emerging or re-emerging human viruses lack an effective vaccine or anti-viral drug
treatment. The recent emergence of the highly pathogenic avian influenza virus H5N1
emphasizes this unmet need. Recent advances in basic and applied research have
provided an unparalleled opportunity to understand the interplay between the virus, the
host, and the immune system, particularly on matters of immune cells and molecules
involved in the generation of immunity, effector mechanisms, and mechanisms involved
in the generation and maintenance of immune memory responses. This meeting will
assemble basic and applied viral immunologists from academia, government, and
industry to foster effective translation of new findings in basic research into effective
vaccines and therapies. The goal of the meeting is to accelerate anti-viral vaccine and
therapeutic development, to facilitate a rapid response to the threat of emerging viruses,
with the focus of the meeting centered on influenza viruses.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
RSV Nanocapsule Vaccine Engineered with a G Protein Peptide Payload
-
批准号:8636392
-
项目类别:
-
资助金额:$56.38万
-
财政年份:2010
-
负责人:RALPH A TRIPP
-
依托单位:
RSV Nanocapsule Vaccine Engineered with a G Protein Peptide Payload
-
批准号:8450155
-
项目类别:
-
资助金额:$52.82万
-
财政年份:2010
-
负责人:RALPH A TRIPP
-
依托单位:
RSV Nanocapsule Vaccine Engineered with a G Protein Peptide Payload
-
批准号:7902985
-
项目类别:
-
资助金额:$59.31万
-
财政年份:2010
-
负责人:RALPH A TRIPP
-
依托单位:
RSV Nanocapsule Vaccine Engineered with a G Protein Peptide Payload
-
批准号:8051743
-
项目类别:
-
资助金额:$57.32万
-
财政年份:2010
-
负责人:RALPH A TRIPP
-
依托单位:
RSV Nanocapsule Vaccine Engineered with a G Protein Peptide Payload
-
批准号:8247796
-
项目类别:
-
资助金额:$55.79万
-
财政年份:2010
-
负责人:RALPH A TRIPP
-
依托单位:
Antibody inhibition of respiratory syncytial virus G protein activity
-
批准号:7179193
-
项目类别:
-
资助金额:$33.62万
-
财政年份:2007
-
负责人:RALPH A TRIPP
-
依托单位:
Antibody inhibition of respiratory syncytial virus G protein activity
-
批准号:7339847
-
项目类别:
-
资助金额:$32.07万
-
财政年份:2007
-
负责人:RALPH A TRIPP
-
依托单位:
Antibody inhibition of respiratory syncytial virus G protein activity
-
批准号:7744001
-
项目类别:
-
资助金额:$31.75万
-
财政年份:2007
-
负责人:RALPH A TRIPP
-
依托单位:
Antibody inhibition of respiratory syncytial virus G protein activity
-
批准号:7552034
-
项目类别:
-
资助金额:$32.07万
-
财政年份:2007
-
负责人:RALPH A TRIPP
-
依托单位:
MECHANISMS OF CYTOTOXIC T CELL SPECIFICTY TO ADENOVIRUS
-
批准号:3030313
-
项目类别:
-
资助金额:$1.71万
-
财政年份:1992
-
负责人:RALPH A TRIPP
-
依托单位:
MECHANISMS OF CYTOTOXIC T CELL SPECIFICTY TO ADENOVIRUS
-
批准号:3030312
-
项目类别:
-
资助金额:$2.99万
-
财政年份:1991
-
负责人:RALPH A TRIPP
-
依托单位:
MECHANISMS OF CYTOTOXIC T CELL SPECIFICTY TO ADENOVIRUS
-
批准号:3030311
-
项目类别:
-
资助金额:$2.8万
-
财政年份:1991
-
负责人:RALPH A TRIPP
-
依托单位:
海外基金